Daniel Lee

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation

Sang Jun Park, H.T. Kim, Daniel Lee et al. · Lung Cancer · 2012 · 325 citations

Medicine, Brain Metastasis, Pathology +7

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Frank Griesinger, Giuseppe Curigliano, Michael Thomas et al. · Annals of Oncology · 2022 · 167 citations · Full text

High resolution <scp>MRI</scp> difference between moyamoya disease and intracranial atherosclerosis

Y. J. Kim, Daniel Lee, Ji-Hee Kwon et al. · European Journal of Neurology · 2013 · 115 citations

RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial

J.L. Lee, M.K. Kim, Inkeun Park et al. · Annals of Oncology · 2015 · 108 citations

Urology, Restore Trial, Genitourinary Cancer +6

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Jong‐Mu Sun, Yong Chan Ahn, Eun Kyung Choi et al. · Annals of Oncology · 2013 · 105 citations · Full text

Adaptive Radiotherapy, Concurrent Thoracic Radiotherapy, Radiation Therapy +9